Exclusive

Publication

Byline

Australia announces $11 M grant to boost Autism research

Singapore, June 25 -- La Trobe University's Olga Tennison Autism Research Centre will receive $11.1 million over three years to establish the Australian Autism Knowledge Hub, as part of the Australian... Read More


Abu Dhabi announces partnership with MSD to advance healthcare operational excellence

Singapore, June 25 -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health - Abu Dhabi (DoH) has announced a collaborati... Read More


ATLATL and Samsung Bioepis to accelerate early-stage biotech innovation across Asia-Pacific

Singapore, June 25 -- China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea's Samsung Bioepis have announced the launch of the Samsung... Read More


Where Asia Builds the Future of Care

Singapore, June 25 -- Healthcare systems across Southeast Asia are navigating a period of unprecedented change. Ageing populations, rising healthcare demands, workforce constraints and rapid technolog... Read More


Ollin raises $330M to advance Phase III retinal disease programme

Singapore, June 25 -- Ollin Biosciences has completed an oversubscribed US$330 million Series B financing to advance global Phase III development of OLN324, also known as IBI324, in retinal vascular d... Read More


CeleCor submits FDA application for investigational heart attack drug

Singapore, June 25 -- CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigational heart attack drug. The filing follows positive Phas... Read More


First PMDA-approved molecular residual disease (MRD) test enters Japan

Singapore, June 24 -- US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has received regulatory approval from Japan's Pharmaceuticals and Med... Read More


Abu Dhabi, Biocom California form life sciences corridor

Singapore, June 24 -- The Department of Health - Abu Dhabi and Biocom California have announced a strategic partnership to create a formal gateway between Abu Dhabi and California's life sciences ecos... Read More


China's Abbisko deepens R&D collaboration with Eli Lilly for novel drug programmes

Singapore, June 24 -- China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based Eli Lilly and Company to discover and develop innovative ... Read More


SystImmune, Biokin Secure First China Approval for Bispecific ADC Iza-bren

Singapore, June 23 -- SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, also known as BL-B01D1, for the treatment of recurrent or met... Read More